Skip to main content
SpringerLink
Log in

Pathology of Malignant Mesothelioma

  • Chapter
Tumors of the Chest

  • 828 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997; 30:403.

    Article  PubMed  CAS  Google Scholar 

  2. Sobin LH, Wittekind IN (eds). Pleural mesothelioma. In: TNM Classification of Malignant Tumours, 6th edn. UICC International Union Against Cancer. New York: Wiley-Liss, 2002:104.

    Google Scholar 

  3. Denton KJ, Cotton DWK, Nakielny RA, Goepel JR. Secondary tumour deposits in needle biopsy tracks: an underestimated risk? J Clin Pathol 1990; 43:83.

    PubMed  CAS  Google Scholar 

  4. Attanoos RL, Gibbs AR. The pathology associated with therapeutic procedures in malignant mesothelioma. Histopathology 2004; 45:393.

    Article  PubMed  CAS  Google Scholar 

  5. Churg A, Roggli V, Galateau-Salle F, et al. Tumours of the pleura. Tumours of the lung, pleura, thymus and heart. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organisation Classification of Tumours. Lyon, France: IARC Press, 2004:125.

    Google Scholar 

  6. Battifora H, McCaughey WTE (eds). Tumours of the serosal membranes. In: Atlas of Tumour Pathology, 3rd series, Fascicle 15 Armed Forces Institute of Pathology. Washington DC: AFIP, 1995.

    Google Scholar 

  7. Battifora H. The pleura. In: Mills SE, Carter D, Greenson JK, et al. (eds) Diagnostic Surgical Pathology. Philadelphia: Lippincott Williams and Wilkins, 2004; 1223.

    Google Scholar 

  8. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern. Histopathology 2001; 39:584.

    Article  PubMed  CAS  Google Scholar 

  9. Roberts F, McCall AE, Burnett RA. Malignant mesothelioma: a comparison of biopsy and post-mortem material by light microscopy and immunohistochemistry. J Clin Pathol 2001; 54:766.

    PubMed  CAS  Google Scholar 

  10. Allen TC, Cagle PT, Churg AM, Colby TV, Gibbs AR, Hammar SP, Corson JM, Grimes MM, Ordonez NG, Roggli V, Travis WD, Wick MR. Localised malignant mesothelioma. Am J Surg Pathol 2005; 29:866.

    Article  PubMed  Google Scholar 

  11. Galateau-Salle F, Vignaud JM, Burke L, Gibbs A, Brambilla E, Attanoos R, Goldberg M, Launoy G; Mesopath Group. Well differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 2004; 28:534.

    PubMed  Google Scholar 

  12. Kaplan MA, Tazelaar HD, Hayashi T, Schroer KR, Travis WD. Adenomatoid tumours of the pleura. Am J Surg Pathol 1996; 20:1219.

    Article  PubMed  CAS  Google Scholar 

  13. Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use of desmin and comparative evaluation with epithelial membrane antigen, p53, platelet derived growth factor receptor, P-glycoprotein and Bcl-2. Histopathology 2003; 43:231.

    Article  PubMed  CAS  Google Scholar 

  14. Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy. Am J Clin Pathol 1998; 110:191.

    PubMed  CAS  Google Scholar 

  15. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol 2002; 55:662.

    Article  PubMed  CAS  Google Scholar 

  16. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003; 27:1031.

    Article  PubMed  Google Scholar 

  17. Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. Hum Pathol 2004;35:697.

    Article  PubMed  CAS  Google Scholar 

  18. Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJ III, Kaiser LR, Albeida SM. Wilms’ tumour 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995; 146:344.

    PubMed  CAS  Google Scholar 

  19. Attanoos RL, Dojcinov SD, Webb R, Gibbs AR. Antimesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 2000; 37:224.

    Article  PubMed  CAS  Google Scholar 

  20. Clover J, Oates J, Edwards C. Anti-cytokeratins 5/6: a positive marker for epithelioid mesothelioma. Histopathology 1997; 31:140.

    Article  PubMed  CAS  Google Scholar 

  21. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of P63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116:823.

    Article  PubMed  CAS  Google Scholar 

  22. Kennedy AD, King G, Kerr KM. HMBE and antithrombomodulin in the differential diagnosis of malignant mesothelioma of the pleura. J Clin Pathol 1997; 50:859.

    PubMed  CAS  Google Scholar 

  23. Ordonez NG. Application of mesothelin immunostaining in tumour diagnosis. Am J Surg Pathol 2003; 27:1418.

    Article  PubMed  Google Scholar 

  24. Doglioni C, Tos APD, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037.

    Article  PubMed  CAS  Google Scholar 

  25. Mayall FG, Gibbs AR. The histology and immunohistochemistry of small cell mesothelioma. Histopathology 1992; 20:47.

    PubMed  CAS  Google Scholar 

  26. Chu P, Wu E, Wiess LM. Cytokeratin 7 and 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13:962.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cellular Pathology, St. George’s Healthcare NHS Trust, London, UK

    Catherine M. Corbishley

Authors
  1. Catherine M. Corbishley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sotiria General Hospital, Athens Medical School, Athens, Greece

    Konstantinos N. Syrigos MD, PhD

  2. Royal Marsden NHS Trust Hospitals, London, UK

    Christopher M. Nutting MB BA, MD, FRCR

  3. Evangelismos General Hospital, Athens Medical School, Athens, Greece

    Charis Roussos MD, MSc, PhD, MRS, FRCP(C)

  4. Faculty of Medicine, McGill University, Montreal, Canada

    Charis Roussos MD, MSc, PhD, MRS, FRCP(C)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Corbishley, C.M. (2006). Pathology of Malignant Mesothelioma. In: Syrigos, K.N., Nutting, C.M., Roussos, C. (eds) Tumors of the Chest. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-31040-1_42

Download citation

  • DOI: https://doi.org/10.1007/3-540-31040-1_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-31039-6

  • Online ISBN: 978-3-540-31040-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation